04/21/2026
This new Executive Order expanding research and accelerating access to psychedelic therapies is a major step forward for people battling addiction.
For too long, families facing opioid, alcohol, methamphetamine, and other substance dependence have had limited options. By increasing federal support for research and creating faster pathways for promising treatments like ibogaine, this order brings new hope to those who need real solutions now.
At the Reid Foundation, we are turning that momentum into action through our Ibogaine Sponsorship Program, helping individuals access treatment when finances stand in the way.
We’re also proud to congratulate Bryan Hubbard, now CEO of Americans for Ibogaine, and former head of the Texas Ibogaine Initiative at the Reid Foundation, for helping champion progress in this space.
Policy creates opportunity. Sponsorship changes lives.
Donate today and help someone reclaim their future.
https://reaching-everyone-in-distress.revv.co/donate-today
Shares of psychedelic drug developers rose on Monday after U.S. President Donald Trump signed an executive order directing health regulators to speed up reviews of psychedelic treatments and increased federal funding for their research.